Chemical composition and cytotoxic properties ofClinacanthus nutansroot extracts / Peik Lin Teoh, Angelina Ying Fang Cheng, Monica Liau, Fui Fui Lem, Grace P. Kaling, Fern Nie Chua, Bo Eng Cheong
Abstract Context: Clinacanthus nutans Lindau (Acanthaceae) is a medicinal plant that has been reported to have anti-inflammatory, antiviral, antimicrobial and antivenom activities. In Malaysia, it has been widely claimed to be effective in various cancer treatments but scientific evidence is lacking. Objective: This study investigates the chemical constituents, anti-proliferative, and apoptotic properties of C. nutans root extracts. Materials and methods: The roots were subjected to solvent extraction using methanol and ethyl acetate. The anti-proliferative effects of root extracts were tested at the concentrations of 10 to 50 μg/mL on MCF-7 and HeLa by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for 72 h. Morphological changes were observed under light microscope. Pro-apoptotic effects of root extracts were examined using flow cytometric analysis and RT-PCR. The chemical compositions of root extracts were detected using GC-MS. Results: The proliferation of MCF-7 cells was inhibited with the IC 50 values of 35 and 30 μg/mL, respectively, for methanol and ethyl acetate root extracts. The average inhibition of HeLa cells was ∼25%. Induction of apoptosis in MCF-7 was supported by chromatin condensation, down-regulation of BCL2 and unaltered expression of BAX . However, only ethyl acetate extract caused the loss of mitochondrial membrane potential. GC-MS analysis revealed the roots extracts were rich with terpenoids and phytosterols. Discussion and conclusions: The results demonstrated that root extracts promote apoptosis by suppressing BCL2 via mitochondria-dependent or independent manner. The identified compounds might work solely or cooperatively in regulating apoptosis. However, further studies are required to address this.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
---|---|
Enthalten in: |
Pharmaceutical biology - 55(2017), 1, Seite 394-401 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Teoh, Peik Lin [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Themen: |
---|
Umfang: |
1 Online-Ressource (8 p) |
---|
doi: |
10.1080/13880209.2016.1242145 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
KFL011777028 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011777028 | ||
003 | DE-627 | ||
005 | 20240111210312.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240110s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/13880209.2016.1242145 |2 doi | |
035 | |a (DE-627)KFL011777028 | ||
035 | |a (KFL)prod_LgpH_10.1080/13880209.2016.1242145 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Teoh, Peik Lin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Chemical composition and cytotoxic properties ofClinacanthus nutansroot extracts |c Peik Lin Teoh, Angelina Ying Fang Cheng, Monica Liau, Fui Fui Lem, Grace P. Kaling, Fern Nie Chua, Bo Eng Cheong |
264 | 1 | |c 2017 | |
300 | |a 1 Online-Ressource (8 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Context: Clinacanthus nutans Lindau (Acanthaceae) is a medicinal plant that has been reported to have anti-inflammatory, antiviral, antimicrobial and antivenom activities. In Malaysia, it has been widely claimed to be effective in various cancer treatments but scientific evidence is lacking. Objective: This study investigates the chemical constituents, anti-proliferative, and apoptotic properties of C. nutans root extracts. Materials and methods: The roots were subjected to solvent extraction using methanol and ethyl acetate. The anti-proliferative effects of root extracts were tested at the concentrations of 10 to 50 μg/mL on MCF-7 and HeLa by using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay for 72 h. Morphological changes were observed under light microscope. Pro-apoptotic effects of root extracts were examined using flow cytometric analysis and RT-PCR. The chemical compositions of root extracts were detected using GC-MS. Results: The proliferation of MCF-7 cells was inhibited with the IC 50 values of 35 and 30 μg/mL, respectively, for methanol and ethyl acetate root extracts. The average inhibition of HeLa cells was ∼25%. Induction of apoptosis in MCF-7 was supported by chromatin condensation, down-regulation of BCL2 and unaltered expression of BAX . However, only ethyl acetate extract caused the loss of mitochondrial membrane potential. GC-MS analysis revealed the roots extracts were rich with terpenoids and phytosterols. Discussion and conclusions: The results demonstrated that root extracts promote apoptosis by suppressing BCL2 via mitochondria-dependent or independent manner. The identified compounds might work solely or cooperatively in regulating apoptosis. However, further studies are required to address this | ||
653 | |a Clinacanthus nutans | ||
653 | |a anti-proliferative | ||
653 | |a apoptosis | ||
653 | |a BAX | ||
653 | |a BCL2 | ||
700 | 1 | |a Cheng, Angelina Ying Fang |e verfasserin |4 aut | |
700 | 1 | |a Liau, Monica |e verfasserin |4 aut | |
700 | 1 | |a Lem, Fui Fui |e verfasserin |4 aut | |
700 | 1 | |a Kaling, Grace P. |e verfasserin |4 aut | |
700 | 1 | |a Chua, Fern Nie |e verfasserin |4 aut | |
700 | 1 | |a Cheong, Bo Eng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical biology |d Abingdon : Taylor & Francis Group, 1961 |g 55(2017), 1, Seite 394-401 |h Online-Ressource |w (DE-627)KFL000005940 |w (DE-600)1483151-X |w (DE-576)273877747 |x 1744-5116 |7 nnns |
773 | 1 | 8 | |g volume:55 |g year:2017 |g number:1 |g pages:394-401 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/13880209.2016.1242145 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-TFE | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_LgpH_01 | ||
951 | |a AR | ||
952 | |d 55 |j 2017 |e 1 |h 394-401 |